Monoclonals and More Issues and Opportunities With Early Treatment Options in COVID-19

ASPR TRACIE. (2021). Monoclonals and More: Issues and Opportunities With Early Treatment Options in COVID-19.
Speakers share current recommendations for use of mAbs and upcoming therapies and the challenges and opportunities that they may pose in conjunction with mAb and other treatments.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.